PRISM MEDICO AND PHARMACY LTD
CIN L24100HP2002PLC009299
CIN L24100HP2002PLC009299
Quick Link
Home I About us I Investor I Management I Contact us
Copyright © 2017 Prism Medico and Pharmacy ltd.
Site Designed By Web1Dzine.com
Follow us
About us
PRISM MEDICO AND PHARMACY LIMITED was originally incorporated on 21st February, 1985 under the Companies act 1956 and obtained certificate for commencement of business from the Registrar of Companies with the Registrar of Companies, Mumbai, Maharashtra on 8th March, 1985.
The Authorised Capital of Prism is Rs. 10.00 Crores divided in to 1,00,00,000 Equity Shares of Face Value of Rs. 10/- each. The Issued, Subscribed and Paid-up capital of Prism is Rs.60634280/-divided in to 6063428 Equity Shares of Face Value Rs. 10/- each. Prism has established its connectivity with both the National Securities Depositiories Limited and Central Depositories Services (India) Limited. The ISIN of Prism is INE730E01016.
The main object of the Prism is to carry on business of manufacturers, buy, sell, deal, export, import, trade, distribute, act as wholesaler, retailer, suppliers, selling agent, buying agent, repackers, analytical chemists, druggist, refiners, processors, merchants and stockiest, in all types of cases kinds/nature, chemicals, serums, chemical products, antibiotics, medicines, drugs, pharmaceuticals pesticide, dyes, soaps oil, perfumes, cosmetic, patent medicine etc.
During the recent previous years, the company has not been able to carry out any major operations and the company is presently engaged in trading. As on date, the Target Company does not have any partly paid-up equity shares. There are no outstanding warrants or options or similar instruments, convertible into Equity Shares at a later stage. Promoters shares are subject to lock in obligations The Equity Shares of Prism are listed on BSE Limited and are not suspended for trading by
BSE. No penal action has been initiated by BSE, except the fact that suspension of our securities on 21.08.2015 for surveillance reasons, however the same has been revoked with effect from 1st July, 2016 vide BSE Notice dated 30th June, 2016 The shares are frequently traded shares on BSE within the meaning of explanation provided in Regulation 2(j) of the SEBI (SAST) Regulations, 2011. The Company has complied with the requirements of the Listing agreement with BSE and as on date further no penal action has been initiated by the BSE.
The Authorised Capital of Prism is Rs. 10.00 Crores divided in to 1,00,00,000 Equity Shares of Face Value of Rs. 10/- each. The Issued, Subscribed and Paid-up capital of Prism is Rs.60634280/-divided in to 6063428 Equity Shares of Face Value Rs. 10/- each. Prism has established its connectivity with both the National Securities Depositiories Limited and Central Depositories Services (India) Limited. The ISIN of Prism is INE730E01016.
The main object of the Prism is to carry on business of manufacturers, buy, sell, deal, export, import, trade, distribute, act as wholesaler, retailer, suppliers, selling agent, buying agent, repackers, analytical chemists, druggist, refiners, processors, merchants and stockiest, in all types of cases kinds/nature, chemicals, serums, chemical products, antibiotics, medicines, drugs, pharmaceuticals pesticide, dyes, soaps oil, perfumes, cosmetic, patent medicine etc.
During the recent previous years, the company has not been able to carry out any major operations and the company is presently engaged in trading. As on date, the Target Company does not have any partly paid-up equity shares. There are no outstanding warrants or options or similar instruments, convertible into Equity Shares at a later stage. Promoters shares are subject to lock in obligations The Equity Shares of Prism are listed on BSE Limited and are not suspended for trading by
BSE. No penal action has been initiated by BSE, except the fact that suspension of our securities on 21.08.2015 for surveillance reasons, however the same has been revoked with effect from 1st July, 2016 vide BSE Notice dated 30th June, 2016 The shares are frequently traded shares on BSE within the meaning of explanation provided in Regulation 2(j) of the SEBI (SAST) Regulations, 2011. The Company has complied with the requirements of the Listing agreement with BSE and as on date further no penal action has been initiated by the BSE.
------------------------------------------------------------------------------------------------------------------------------------------------------
EmailD: info@prismmedico.com